Key result
Pre-procedural transoesophageal echocardiography detected left atrial thrombus in 1.9% of patients undergoing atrial fibrillation ablation, with no thrombi found in those without clinical risk factors.
Why the study?
What is the incidence and what are the clinical predictors of left atrial thrombus detected by pre-procedural transoesophageal echocardiography in patients undergoing atrial fibrillation ablation?
Cohort (n=635)
What is the incidence and what are the clinical predictors of left atrial thrombus detected by pre-procedural transoesophageal echocardiography in patients undergoing atrial fibrillation ablation?
Pre-procedural transoesophageal echocardiography to screen for left atrial thrombus prior to atrial fibrillation ablation may be safely omitted in patients without clinical risk factors for stroke.
Answers are grounded in this paper and cite their sources.
May support selective omission of pre-procedural TEE in low-risk AF ablation patients; leaves open need for randomized confirmation.
AIMS: The exact role of transoesphageal echo (TOE) prior to atrial fibrillation (AF) ablation remains unclear. This study examines the incidence and predictors of left atrial (LA) thrombus in patients undergoing AF ablation. METHODS AND RESULTS: Patients were treated with warfarin for at least 4 weeks prior to ablation. This was substituted with therapeutic dalteparin 3 days before the procedure. All patients underwent TOE to exclude LA thrombus. Six clinical risk factors for thrombus were defined, known to be risk factors for stroke in AF: age>75, diabetes, hypertension, valve disease, prior stroke, or transient ischaemic attack and cardiomyopathy. A total of 635 procedures were performed. The incidence of thrombus was 12/635 (1.9%) despite therapeutic anti-coagulation. Patients with thrombus had larger LA diameter, mean 50.6+/-6.2 mm vs. 44.2+/-7.6 (P=0.006). In univariate analysis, persistent AF [odds ratio (OR)=10.4 with 95% CI 1.8-19.1], hypertension [OR=11.7 with 95% CI 2.5-54.1], age>75 (OR=4.5 with 95% CI 1.2-17.2), and cardiomyopathy (OR 5.9 with 95% CI 1.8-19.1) were significantly associated with thrombus. In multivariate analysis, hypertension (OR=14.2 with 95% CI 2.6-77.5), age>75 (OR=8.1, 95% CI 1.5-44.9), and cardiomyopathy (OR=10.5 with 95% CI 2.6-77.5) were independently associated with thrombus. There was no thrombus in patients without clinical risk factors. CONCLUSION: In patients presenting for AF ablation, LA thrombus is only seen in those with clinical risk factors. TOE is indicated in this group but may be unnecessary in patients without clinical risk factors.
No takes yet. Share an insight, caveat, or question.
McCready et al. (2010) conducted a cohort in Atrial fibrillation (n=635). Transoesophageal echocardiography (TOE) was evaluated on Incidence of left atrial thrombus. Pre-procedural transoesophageal echocardiography detected left atrial thrombus in 1.9% of patients undergoing atrial fibrillation ablation, with no thrombi found in those without clinical risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: